Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement AE Monitoring System Would Receive $2.5 Mil. In 2001 Budget

This article was originally published in The Tan Sheet

Executive Summary

The Clinton Administration's budget for FY 2001, released Feb. 7, would allocate $2.5 mil. to CFSAN for an adverse event monitoring system for dietary supplements.

You may also be interested in...



Supplement AER Monitoring System Funding Request Lowered For FY 2002

Upgrades to FDA's dietary supplement adverse event monitoring system would be financed with $1 mil. in funding under the Bush Administration's fiscal year 2002 budget proposal.

Supplement AER Monitoring System Funding Request Lowered For FY 2002

Upgrades to FDA's dietary supplement adverse event monitoring system would be financed with $1 mil. in funding under the Bush Administration's fiscal year 2002 budget proposal.

Supplement AER Monitoring System Funding Request Lowered For FY 2002

Upgrades to FDA's dietary supplement adverse event monitoring system would be financed with $1 mil. in funding under the Bush Administration's fiscal year 2002 budget proposal.

Related Content

Topics

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel